ABSTRACT: Glycosaminoglycans (GAGs) are known to participate in central nervous system processes such as development, cell migration, and neurite outgrowth. In this paper, we report an initial glycomics study of GAGs from the porcine central nervous system. GAGs of the porcine central nervous system, brain and spinal cord were isolated and purified by defatting, proteolysis, anion-exchange chromatography, and methanol precipitation. The isolated GAG content in brain was 5 times higher than in spinal cord (0.35 mg/g of dry sample, compared to 0.07 mg/g of dry sample). In both tissues, chondroitin sulfate (CS) and heparan sulfate (HS) were the major and the minor GAG, respectively. The average molecular masses of CS from brain and spinal cord were 35.5 and 47.1 kDa, respectively, and those for HS from brain and spinal cord were 56.9 and 34 kDa, respectively. The disaccharide analysis showed that the compositions of CS from brain and spinal cords are similar, with uronic acid (1f3) 4-O-sulfo-N-acetylgalactosamine residue corresponding to the major disaccharide unit (CS type A) along with five minor disaccharide units. The major disaccharides of both brain and spinal cord HS were uronic acid (1f4) N-acetylglucosamine and uronic acid (1f4) 6-O-sulfo-Nsulfoglucosamine, but their composition of minor disaccharides differed. Analysis by 1 H and two-dimensional NMR spectroscopy confirmed these disaccharide analyses and provided the glucuronic/iduronic acid ratio. Finally, both purified CS and HS were biotinylated and immobilized on BIAcore SA biochips. Interactions between these GAGs and fibroblast growth factors (FGF1 and FGF2) and sonic hedgehog (Shh) were investigated by surface plasmon resonance.
Brain and spinal cord are the two main components of the central nervous system (CNS). 1 The extracellular matrix of the CNS serves as both a supporting structure for cells and a rich source of signaling molecules that can influence cell proliferation, survival, migration, and differentiation (1) .
Chondroitin sulfate proteoglycans (CSPGs), known to be diffusely present in the CNS matrix and the condensed matrix of perineuronal nets (PNNs) (2) , are involved in the regulation of neuronal plasticity (3, 4) , in neuroprotection (5, 6) , and in support of ion homeostasis around highly active neurons (7) (8) (9) . The polysaccharide component of CSPGs, the CS GAGs are key to the binding and biological activities of CSPGs, as the result of the positioning of sulfo groups by specific saccharide sequences. There is a growing body of evidence that shows that CS is a uniquely important GAG in morphogenesis, cell division, and cartilage development. CSPGs are spatiotemporally regulated during brain development and upregulated after injury in the CNS. CS is a sulfated GAG composed of a repeating disaccharide backbone of f4) β-D-glucuronic acid (GlcA) (1f3) β-D-Nacetylgalactosamine (GalNAc) (1f potentially containing some L-iduronic acid (IdoA) residues and O-sulfo group substitution. GlcA containing CS can belong to class CS-A (chondroitin 4-sulfate), CS-C (chondroitin 6-sulfate), CS-D (chondroitin 2,4-disulfate), or CS-E (chondroitin 4,6-disulfate). Class CS-B (dermatan sulfate) is comprised of a 4-O-sulfo-GalNAc 1f4 linked to IdoA. Nonsulfated (chondroitin) disaccharide can also be found in the CS structure. Studies relying on synthetic approaches using carbohydrate microarrays have demonstrated that CS-E is the principal motif involved in the interaction of CS with midkine, a heparin-binding growth factor involved in neural development (10) . Chondroitin 4-sulfate (CS-A) also has been shown to negatively regulate axonal guidance and growth (11) (12) (13) (14) (15) (Figure 1 ).
HS consists of f4) β-D-GlcA (or IdoA) (1f4) β-D-N-acetylglucosamine (GlcNAc) (1f with various N-sulfo and O-sufo subtitutions (16) . HS PGs are ubiquitous in all animal tissues and are also found in brain and nervous tissue. HS PG glypican-2 (cerebroglycan), for example, is uniquely important in the developing nervous system and is expressed predominantly during neuronal differentiation (17) . HS can mediate repulsion and collapse of olfactory axons (18) and is essential for the binding of various growth factors (19) and Semaphorin 5A (20) .
Glycomics research is currently undergoing rapid development as a result of recent advances in technologies for glycan structural † This work was supported by grants from the National Institutes of Health (GM38060) and the New York State Spinal Cord Injury Program (C022061 to R.J.L.). Z.L. was supported by China Scholarship Council.
*To whom correspondence should be addressed. Phone: (518) 276-6839. Fax: (518) 276-3405. E-mail: zhangf2@rpi.edu.
1 Abbreviations: CNS, central nervous system; CSPGs, chondroitin sulfate proteoglycans; HS, heparan sulfate; PGs, proteoglycans; CS, chondroitin sulfate; SPR, surface plasmon resonance; FGF, fibroblast growth factor; Shh, sonic hedgehog; GAG, glycosaminoglycan; ECM, extracellular matrix; SA, streptavidin; FC, flow cell; PAGE, polyacrylamide gel electrophoresis; MW, molecular weight; CO, cutoff; GlcA, glucuronic acid; GalNAc, N-acetylgalactosamine; IdoA, iduronic acid; GlcNAc, N-acetylglucosamine; LC-MS, liquid chromatography and mass spectrometry; NMR, nuclear magnetic resonance; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate; RU, resonance unit.
analysis that is beginning to unravel the structure-activity relationships of glycan-protein interactions (21) . In this paper, we report an initial glycomics study of GAGs from the porcine CNS. CS and HS were isolated from porcine brain and spinal cords, purified, and quantified, and their average molecular weight (MW avg ) was determined. Disaccharide composition, determined using liquid chromotography and mass spectrometry (LC-MS), and structural analysis relying on 1 H and two-dimensional NMR spectroscopy were conducted. These purified CS and HS GAGs were biotinylated and immobilized on BIAcore SA biochips, and their interactions with fibroblast growth factors (FGF1 and FGF2) and sonic hedgehog (Shh) were investigated using surface plasmon resonance (SPR).
EXPERIMENTAL PROCEDURES
Materials. Adult healthy porcine brains (two brains) and spinal cords (four cords) were purchased from Pel-freez Biological Inc. (Rogers, AR). Actinase E was from Kaken Biochemicals (Tokyo, Japan). CS-A (bovine tracheal cartilage) and CS-E (squid cartilage) and chondroitin lyases (ABC and ACII) were from Seikagaku Corp. (Tokyo, Japan). HS (porcine intestine) was from Celsus Laboratories (Cincinnati, OH). Flavobacterial heparin lyases I, II, and III were expressed in Escherichia coli and purified in our laboratory. Polyacrylamide, urea, CHAPS, Alcian blue dye, 2-cyanoacetamide, and tetra-n-butylammonium hydrogen sulfate were from Sigma (St. Louis, MO).
Unsaturated CS disaccharide standards [Di-0S, ΔUA-GalNAc (where ΔUA is Δ-deoxy-L-threo-hex-4-enopyranosyluronic acid); Di-4S, ΔUA-GalNAc4S; Di-6S, ΔUA-GalNAc6S; Di-UA2S, ΔUA2S-GalNAc; Di-diS B , ΔUA2S-GalNAc4S; Di-diS D , ΔUA-2S-GalNAc6S; Di-diS E , ΔUA-GalNAc4S6S; Di-triS, ΔUA2S-GalNAc4S6S] and unsaturated heparin/HS disaccharide standards (Di-0S, ΔUA-GlcNAc; Di-NS, ΔUA-GlcNS; Di-6S, ΔUA-GlcNAc6S; Di-UA2S, ΔUA2S-GlcNAc; Di-UA2SNS, ΔUA2S-GlcNS; Di-NS6S, ΔUA-GlcNS6S; Di-UA2S6S, ΔUA2S-GlcNAc6S; Di-triS, ΔUA2S-GlcNS6S) were obtained from Seikagaku Corp.
Fibroblast growth factor 1 (FGF1) and fibroblast growth factor 2 (FGF2) were gifts from Amgen (Thousands Oaks, CA). Sonic hedgehog (Shh) was generously provided by D. Leahy (Johns Hopkins University, Baltimore, MD).
Methods. (i) Isolation and Purification of GAGs. Porcine brain and spinal cord samples were crushed with dry ice into very fine homogenized powder using a blender (from Fisher Scientific). Fat was removed by washing the tissues with a chloroform/ methanol mixture [2:1, 1:1, 1:2 (v/v)] each left overnight. Defatted samples were proteolyzed at 55°C with 10% actinase E (20 mg/ mL) for 18 h. After the proteolysis, dry urea and dry CHAPS were added to each sample (2 wt % in CHAPS and 8 M in urea). The resulting cloudy solutions were clarified by being passed through a syringe filter containing a 0.2 μm membrane from Millipore (Billerica, MA). A Vivapure MAXI Q H spin column was equilibrated with 3 mL of 8 M urea containing 2% CHAPS (pH 8.3). The clarified filtered samples were loaded onto and run through the Vivapure MAXI Q H spin columns (Sartoriou Stedim Biotech, Bohemia, NY) under centrifugal force (500g). The columns were first washed with 3 mL of 8 M urea containing 2% CHAPS (pH 8.3). The columns were then washed five times with 5 mL of 200 mM NaCl. GAG was recovered from the spin column after it was washed three times with 1 mL of 16% NaCl; these washes were collected and combined, and methanol (12 mL) was added to afford an 80 vol. % methanol solution that was equilibrated at 4°C for 18 h, resulting in a precipitate that was recovered by centrifugation (2500g) for 30 min. The precipitate was dissolved in 0.5 mL of water, and the recovered total GAGs were stored frozen for further analysis.
(ii) Isolation of CS and HS from the Total GAG Mixture. GAG samples were digested with a mixture of heparin lyases I, II, and III (10 milliunits each) at 35°C for 38 h to isolate CS. CS was purified with a Vivapure MINI Q H spin column and centrifugal filtration using a 3000 Da molecular weight cutoff (MWCO) membrane (Millipore, Bedford, MA). HS was recovered by digestion of total GAGs with chondroitinase ABC and chondroitinase ACII (5 milliunits each) at 37°C for 38 h. The HS products were recovered with the same process as CS. HS was purified with a Vivapure MINI Q H spin column and centrifugal filtration using a 3000 Da MWCO membrane. The total GAGs, CS, and HS were quantified by a carbazole assay (22) using CS-A as the standard.
(iii) Polyacrylamide Gel Electrophoresis Analysis. Polyacrylamide gel electrophoresis (PAGE) was used to determine the MW avg and polydispersity of each GAG sample. In each lane, ∼5 μg of total GAG, CS, or HS was subjected to electrophoresis against a standard composed of a mixture of oligosaccharides with known molecular weights that had been prepared enzymatically from bovine lung heparin. The gel was visualized with Alcian blue staining and then digitized with UN-Scan-it (Silk Scientific), and MW avg and polydispersity were calculated (23) .
(iv) Disaccharide Analysis Using LC-MS. The GAG substrate (20 μg/μL) was treated with 5 μL of a mixture of 0.1 unit each of chondroitin lyase ABC and chondroitin lyase ACII dissolved in 500 μL of 0.1% BSA and incubated at 37°C overnight. The products were filtered using 3000 Da MWCO centrifugal filters, and the CS disaccharides were recovered in the filtrate. The disaccharides were freeze-dried, and exactly 100 μL of H 2 O was added prior to their analysis. Next, heparin lyase I, II, and III [3 milliunit each in 10 μL of sodium phosphate (5 mM, pH 7.1) buffer] were added to the retentate, and the mixture was incubated at 37°C overnight. The products were again filtered using 3000 Da MWCO centrifugal filters, and the HS disaccharides were recovered in the filtrate. The disaccharides were freeze-dried, and exactly 100 μL of H 2 O was added prior to their analysis.
Disaccharide analysis was performed on a LC-MS system (Agilent LC/MSD trap MS). Solutions A and B for the HPLC separation contained 37.5 mM NH 4 HCO 3 and 11.25 mM tributylamine in 15 and 70% acetonitrile, respectively. The pH values of these solutions were adjusted to 6.5 with acetic acid. Separation was performed on a C-18 column [2.1 mm Â 150 mm (Waters, Milford, MA)] at a flow rate of 10 μL/min using solution A for 20 min, followed by a linear gradient from 20 to 45 min from 0 to 50% solution B. The column effluent entered the source of the ESI-MS for continuous detection by MS. The electrospray interface was set in the negative ionization mode with a skimmer potential of -40.0 V, a capillary exit at -40.0 V, and a source temperature of 325°C to obtain the maximum abundance of the ions in full scan spectra (150-1500 Da, 10 full scans/s). Nitrogen was used as a drying (5 L/min) and nebulizing gas (20 psi). The CS disaccharide separation was performed on an Acquity UPLC BEH C18 column [2.1 mm Â 150 mm, 1.7 μm (Waters)] using solution A for 10 min, followed by a linear gradient from 10 to 40 min from 0 to 50% solution B. The column temperature was maintained at 45°C. The flow rate was 100 μL/ min. Solutions A and B for UPLC were 0 and 75% acetonitrile, respectively, containing the same concentration of 15 mM hexylamine (HXA) as an ion pairing reagent and 100 mM 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) as an organic modifier. We extracted the ions on the basis of their theoretical mass unit, ionization mode, and addition of ion pairing reagent.
(v) NMR Analysis. Total GAG, CS, and HS isolated from porcine brain and porcine spinal cord were analyzed by (vi) Biotinylation of GAG. CS and HS (300 μg) were incubated in a 500 mM NaOH solution at 4°C for 16 h and then neutralized by gradual addition of glacial acetic acid to cleave the xylose-serine linkage. The products were desalted using a YM-3 spin column. The resulting CS and HS GAG chains (200 μg) and amine-PEO 3 -biotin (200 μg) were dissolved in 100 μL of H 2 O, then 10 μg of NaCNBH 3 was added. The reaction mixture was heated at 70°C for 24 h, and a further 10 mg of NaCNBH 3 was added and the mixture heated at 70°C for an additional 24 h. After cooling to room temperature, the mixture was desalted with a spin column (3000 Da MWCO). Biotinylated GAGs were collected, freeze-dried, and used for SA chip preparation.
(vii) Preparation of the SPR Biochip. SPR was performed on a BIAcore3000 (GE Healthcare, Uppsala, Sweden). Buffers were filtered (0.22 μM) and degassed. The biotinylated GAGs were immobilized on flow cells in a streptavidin chip. A flow cell was treated with biotin alone and served as a control. The successful immobilization of GAG was confirmed by the observation of an ∼300 resonance unit (RU) increase in the sensor chip. Two chips were prepared: the HS chip immobilized with HS from brain, HS from spinal cord, and commercial HS as a positive control and the CS chip immobilized with CS from brain, CS from spinal cord, and commercial CS-E as a positive control.
(viii) Kinetic Measurements of Protein-GAG Interaction Using SPR. The protein sample (FGF1, FGF2, and Shh) was diluted in HBS-EP buffer [0.01 M Hepes (pH 7.4), 0.15 M NaCl, 3 mM EDTA, and 0.005% surfactant P20] (GE Healthcare). Different dilutions of protein samples in buffer were injected at a flow rate of 30 μL/min. At the end of the sample injection (180 s), the same running buffer was passed over the sensor surface to facilitate dissociation for 180 s. After dissociation, the sensor surface was regenerated by injection of 2 M NaCl. The response was monitored as a function of time (sensorgram) at 25°C. SPR experiments were conducted in duplicate or triplicate at each concentration to confirm the bindings were repeatable. Multiconcentration data were globally fit, and residuals were calculated and used to assess the goodness of fit.
RESULTS

GAG Purification and Quantification.
A simple four-step procedure involving defatting, protease digestion, strong anionexchange chromatography on a spin column, and methanol precipitation was used to isolate GAGs from the porcine brain and spinal cord. This method had been previously established in our laboratory for the quantitative isolation of heparin from human plasma (24) ( Table 1) . After being freeze-dried and weighed, the samples were defatted. As expected, both spinal cord and brain showed a high fat content of 85 and 69% [(grams of fat per gram of dry weight) Â 100], respectively. The total GAG isolated from each sample was next determined using the carbazole assay for uronic acid. The GAG content of the dry, defatted sample from brain (0.35 mg/g) was 5 times higher than the GAG content of spinal cord (0.07 mg/g). CS and HS were each purified from the total GAG by selective polysaccharide digestion using heparin and chondroitin lyases, respectively. The CS/HS ratio in porcine spinal cord was 5.9 and in porcine brain was 3.4.
Polyacrylamide Gel Electrophoresis (PAGE) Analysis (see Figure S1 of the Supporting Information for gel pictures). Total GAGs, CS and HS, isolated from the brain and spinal cord were analyzed by using PAGE with Alcian blue staining. PAGE analysis established that CS and HS were both present in spinal cord and brain and showed a broad band of expected polydispersity Similarly, CS/DS GAGs also can contain different disaccharide sequences, including those corresponding to the eight CS/DS disaccharide standards. An LC-MS analysis method that relies on ion pairing reversed-phase capillary HPLC was used to determine the GAG disaccharide composition (25, 26) . This method affords good resolution in the separation of eight heparin/HS or eight CS/DS disaccharides (see Figures S2-S5 of the Supporting Information for MS spectra). CS and HS from porcine brain and spinal cords were first digested with chondroitin lyase ABC and chondroitin lyase AC II or heparin lyases I, II, and III, followed by disaccharide composition analysis using LC-ESI-MS. All peaks are conclusively identified by retention time and via their mass spectra (see Figures S2-S5 of the Supporting Information for MS spectra). The results (Figure 2 A) showed that the major disaccharide of CS was ΔUA-GalNAc4S (>83 and >73% in brain and spinal cord, respectively). In addition, ΔUA-GalNAc, ΔUA-GalNAc6S, small amounts of ΔUA2S-GalNAc6S, ΔUA2S-GalNAc4S, and ΔUA4S-GalNAc6S were also observed in CS from both tissues. The major disaccharides of HS (Figure 2 B) from both brain and spinal cord were ΔUA-GlcNAc (∼60%) and ΔUA2S-GlcNS6S (∼25%). There were some differences in the minor HS disaccharide composition of porcine brain and porcine spinal cord. ΔUA-GlcNS6S and ΔUA2S-GlcNS were found in brain HS, while ΔUA-GlcNS and ΔUA-GlcNAc6S were found in spinal cord HS.
NMR Spectra. Because there are no detailed reports about the structural characterization of the GAGs from porcine brain and spinal cord, one-dimensional (1D) NMR analysis and twodimensional (2D) NMR analysis of the GAGs were performed. 1 H NMR spectra and 2D NMR (HMQC and COSY) of total GAGs from porcine brain and spinal cord along with 1 H NMR spectra of CS and HS were obtained (Table 2 and Figures 3 and 4) . .00 ppm, the signals of H2 of GlcNS6S and H1 of IdoA of HS, respectively. The ratio of GlcA to IdoA in the total GAG samples from brain and spinal cord is >10 based on the integration of the intense 4.393 ppm peak for GlcA (in both CS and HS) and the 5.00 ppm peak for IdoA. The ratio of the 4.478 ppm signal for GalNAc, the hexoamine unit in CS, and the 5.38 ppm signal GlcNAc, the hexoamine unit in HS, was 9:1, corresponding closely to the ratio of CS to HS in both tissues that was obtained using the carbazole assay ( Table 1) H NMR spectra of total GAG from the two tissues were recorded at an elevated temperature (323 K) to confirm that chondroitin 4-sulfate (CS-A) was the main GAG component in porcine brain and porcine spinal cord (Figure 3, inset) . At 323 K, all the signals of GAGs shift downfield by ∼0.3 ppm. The strong peak at 5.00 ppm was identified as H-4 of GalNAc4S; this peak overlapped with the HOD signal in the 1 H NMR spectra at 298 K. The HMQC spectra of total acidic GAGs from brain and spinal cord were also overlaid onto the HMQC spectrum of CS-A (Figure 4) . The correlation signals of the CS-A covered all the major peaks present in the HMQC spectra of GAGs from both brain and spinal cord.
SPR Measurements of the Interaction of Proteins with CS and HS from Porcine Brain and Spinal Cord. The interactions between the GAGs and proteins from the fibroblast growth factor signaling system (FGF1 and FGF2) and hedgehog signaling pathway (Shh) were investigated using surface plasmon resonance (SPR) to determine the bioactivities of GAGs from two tissues of porcine CNS. The results (Table 3 and Figure 5 ) showed that brain CS had negligible (>1 μM K D ) binding for all proteins except for Shh. Spinal cord HS bound tighter than brain HS to all proteins tested. Brain and spinal cord CS bound Shh (<1 μM K D ) even while the more highly charged CS-E failed to interact. Shh showed very slow off rates compared to those determined for FGF1 and FGF2. Spinal cord HS and CS showed very strong binding to FGF1 and FGF2, while brain CS only weakly bound these growth factors.
DISCUSSION
Over the past few decades, genomics and proteomics have led to high-throughput measurements of expression of several thousand genes and hundreds of protein-protein interactions required for understanding comprehensive biochemical pathways and interaction networks within cells and organisms. Applying the same "omics" concept in glycobiology, or glycomics, requires a multidimensional approach involving isolation, structural characterization, and functional studies of glycans that eventually can lead to important structure-function relationships (27) . Glycomics necessarily relies on a diverse range of analytical technologies, including MS, NMR, HPLC, CE, SPR, arrays, natural and synthetic glycan libraries, microfluidic systems, bioinformatics, and molecular modeling of glycans. The most extensively studied complex glycans are the GAGs, which involved in many critical biological processes, including development, angiogenesis, anticoagulation, axonal growth, cancer, and microbial/viral pathogenesis.
As part of our interest in the treatment of spinal cord injury with chondroitin lyases (28), a class of enzymes extensively studied in our laboratory (29), we became interested in the GAGs present in the CNS. Despite research activity in this area, it was surprising to discover how little was known about the GAG content, structure, and protein binding affinities of CNS PGs in adult mammals. Approximately 20% of the volume of the adult CNS is occupied by extracellular matrix (ECM), which is composed primarily of PGs (30) . The major proteoglycans found in the CNS are members of the lectican family, which have a protein core whose N-terminus binds to hyaluronan (HA) and a middle portion that contains attachment sites for CS GAG chains. It is known that CSPGs are widely expressed in the developing and adult central nervous system (CNS). They have been implicated in regulating cell proliferation, survival, migration, and differentiation. Furthermore, CSPGs are the principal inhibitory component of glial scars, which form after damage to the adult central nervous system and act as a barrier to regenerating axons (31) . CSPGmediated inhibition of growth seems to be linked to the activation of several signaling pathways. Thus, the importance of these critical functions of the CSPGs in CNS suggested that we undertake a glycomics study of porcine CNS for which brain and spinal cord tissues are readily available as a model for the human CNS.
This study reveals that the brain has a 5-fold higher GAG content than the spinal cord. CS is the prominent GAG in CNS PGs (both brain and spinal cord), corresponding to 77-86%, with HS being a minor component (14-23%) in total GAG (Table 1) . While brain CS had a 30% lower MW avg than spinal cord CS, both exhibited comparable disaccharide analyses (Table 1 and Figure 2 ). CNS CS is primarily (>70%) chondroitin 4-sulfate (CS-A) sequences, followed by nearly equal amounts (∼10-15% each) of chondroitin and chondroitin 6-sulfate CS-C sequences, and minor amounts (<1% each) of disulfated sequences [chondroitin 2,6-sulfate (CS-D), chondroitin 4,6-sulfate (CS-E), and chondroitin 2,4-sulfate]. NMR analysis fails to detect the presence of significant amounts of IdoA, suggesting little if any DS is present in the porcine CNS. The placement of these disaccharides into larger sequence motifs, however, appears to be different, resulting in selective binding critical in CNS growth and development. Brain CS shows no measurable binding to FGF1 and weak binding to FGF2, while spinal cord CS binds tightly to both growth factors. Interestingly, spinal cord CS binds these FGFs with greater affinity than the more highly sulfated CS-E. Thus, it is clear that while similar in disaccharide composition, brain CS and spinal cord CS exhibit different protein binding affinities, suggesting that the sequence or arrangement of these disaccharides is critical to their biological function.
We next turned our attention to the HS present in the CNS. Brain HS was ∼30% larger than spinal cord HS, while both contained nearly identical amounts of two major disaccharides, the expected unsulfated disaccharide (∼60%) and the unusual trisulfated disaccharide (∼24%), possibly corresponding to low and high sulfate domains associated with HS-based signaling (32) . In contrast, the contents of monosulfated and disulfated disaccharides in the brain and spinal cord HS were very different, with the brain HS being richer in disulfated disaccharides and the spinal cord HS being richer in monosulfated disaccharides. A comparison of our results, on the HS disaccharide composition of mammalian brain, with those from other investigators demonstrates a relative abundance of the TriS disaccharide (20-25% in porcine brain). This value is considerably higher than the results obtained with bovine brain in our laboratory (33) and rat brain by others (34, 35) . In these prior publications, the percent TriS was <5%. This unexpectedly high abundance of TriS in the HS from porcine brain and spinal cord tissues might result from the higher recovery of the highly sulfated HS chains compared to the undersulfated HS chains causing an enrichment of HS chains containing TriS during the extraction process. It is noteworthy that the structural differences have been reported for GAGs isolated from different species or different organ systems within given single species and even within the same organ system of a single species at different stages of development.
Differences in either composition or sequence result in a consistent higher binding affinity of spinal cord HS for FGF1, FGF2, and Shh. C HMQC spectrum (600 MHz) for total GAG from brain (green) overlaid onto CS-A (blue) (A) and total GAG from spinal cord (red) overlaid onto CS-A (blue) (B) at 298 K. A for GlcA and G for GalNAc. Extensive studies of the FGF family show their multiple critical roles in the formation of the CNS from the early stage of neural induction through the late stage of terminal differentiation (36) . FGF1 and FGF2 have been found to be potent modulators of proliferation in the developing nervous system (37). Recently, it was reported that FGF1 was a potent neurotrophic factor that affects neuronal survival in the injured spinal cord (38) . FGF signaling begins with the formation of a ternary complex of FGF, FGF receptor (FGFR), and HS. HS serves primarily as a template for the assembly of the FGF 2 -FGFR 2 -HS 2 signal transduction complex (39) . It is noteworthy that most HS species used to study FGF signaling have been obtained from porcine intestine used in the commercial preparation of heparin; few if any reports have examined the FGF binding of tissue specific GAGs.
Shh is a member of the hedgehog family of signaling molecules identified by homology to Drosophila hedgehog. Shh was identified as a morphogen that is directly responsible for dorso-ventral patterning of the CNS. Additional multiple actions of Shh during CNS development have been well established, including the specification of oligodendrocytes, proliferation of neural precursors, and control of axon growth (40) . Recently, Lowry et al. reported that the transplantation of endothelial-expanded neural stem cells treated with Shh and retinoic acid into an adult mouse spinal cord injury model resulted in significant recovery of sensory and motor function (41) . In the hedgehog signaling pathway, HSPGs are essential for the proper distribution and signaling activity of signaling proteins (42) . It is well established that Shh interacts with heparin and HS, and these interactions are important for normal hedgehog signaling (38, 43) . Thus, it is interesting that Shh binds both porcine brain and porcine spinal cord CS with higher affinity than HS from the same tissues.
In conclusion, glycosaminoglycans (GAGs) were successfully isolated and purified from the central nervous system (brain and spinal cord). Their molecular structure (i.e., average molecular weight and disaccharide composition) was characterized by PAGE and LC-MS disaccharide analysis, and more detailed structural features were revealed by 1 H and two-dimensional NMR spectroscopy. Finally, interactions between these GAGs and proteins [including fibroblast growth factors (FGF1 and FGF2) and sonic hedgehog (Shh)] were investigated by SPR, providing important structure-activity information. The methodology described will be useful in tissue specific glycomics research in discovering novel glycotherapeutics that target disease-related protein-GAG interactions.
SUPPORTING INFORMATION AVAILABLE
PAGE analysis of GAGs ( Figure S1 ) and MS spectra ( Figure  S2-S5 ). This material is available free of charge via the Internet at http://pubs.acs.org.
